Join Our Team
Thyas Co. Ltd., a Kyoto University spin-off, Closes JPY 2.1B Series B Financing from Eight Roads Ventures/F-Prime to Develop Novel iPSC-derived Immune Cell Platform
Change of board structure
Announcement of Series A3 financing
Joint research on personalized cancer immunotherapy using regenerated T cells derived from iPS cells
Dr. Shin Kaneko published a new article in Nature Biomedical Engineering.
New license agreement with iPS Academia Japan, Inc.
Basic agreement and joint research agreement with the CiRA Foundation
Dr. Shin Kaneko published a new article in Nature Communications.
Contract with Ki-CONNECT for academic advisory support.
Change of board structure.